| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |